685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER, NJ
Annual Report to Security Holders
Bringing Life Into Balance Overview May 2026
Amendment to Merger Agreement Between VYNE Therapeutics and Yarrow
Merger with Yarrow Bioscience
VYNE Therapeutics Inc. Annual Meeting Results - Director Elections Held
Reports 2025 Third Quarter Financial Results and Provides Business Update
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
FY 2024
Q3
Q2
Q1
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
S-4/A
S-4
Prospectus Filed Pursuant to Rule 425
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Correspondence
Submission Upload